BRCA Mutation and Its Association With Colorectal Cancer

Clin Colorectal Cancer. 2018 Dec;17(4):e647-e650. doi: 10.1016/j.clcc.2018.06.006. Epub 2018 Jul 3.

Authors

Aixa E Soyano¹, Candice Baldeo¹, Pashtoon M Kasi²

Affiliations

¹ Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
² Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL. Electronic address: kasi.pashtoon@mayo.edu.

PMID: 30033118
DOI: 10.1016/j.clcc.2018.06.006

No abstract available

Keywords: BRCA; Colorectal cancer; Lynch syndrome; PARP inhibitors; Young onset.

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / therapeutic use
BRCA1 Protein / genetics*
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / genetics*
Colorectal Neoplasms / pathology*
Humans
Male
Mutation*
Oxaliplatin / therapeutic use*
Prognosis

Substances

Antineoplastic Agents
BRCA1 Protein
BRCA1 protein, human
Oxaliplatin